Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MGA012
MGA012
Incyte grabs a new PD-1 checkpoint drug in $900M deal with MacroGenics
Endpoints
Wed, 10/25/17 - 09:44 am
Incyte
PD-1 inhibitors
Macrogenics
MGA012